Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia. [electronic resource]
Producer: 20160621Description: e0140930 p. digitalISSN:- 1932-6203
- Antifungal Agents -- administration & dosage
- Chemotherapy-Induced Febrile Neutropenia -- complications
- Cost-Benefit Analysis
- Costs and Cost Analysis
- Decision Trees
- Diagnostic Tests, Routine -- economics
- Drug Administration Schedule
- Drug Costs
- Early Diagnosis
- Epidemiologic Studies
- Feasibility Studies
- Galactose -- analogs & derivatives
- Health Care Costs
- Hematologic Neoplasms -- complications
- Humans
- Immunocompromised Host
- Lung Diseases, Fungal -- diagnosis
- Mannans -- blood
- Mycoses -- diagnosis
- Opportunistic Infections -- diagnosis
- Randomized Controlled Trials as Topic
No physical items for this record
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Review
There are no comments on this title.
Log in to your account to post a comment.